Clinical safety assessment of oral higenamine supplementation in healthy, young men
Abstract
Objective: Higenamine, an herbal agent also known as norcoclaurine, is thought to stimulate β-androgenic receptors and possess lipolytic activity. It is currently making its way into the dietary supplement market. To our knowledge, no studies have been conducted to determine the safety profile of oral higenamine when used alone and in conjunction with other commonly used lipolytic agents. Methods: Forty-eight men were assigned to ingest either a placebo, higenamine, caffeine, or higenamine + caffeine + yohimbe bark extract daily for a period of 8 weeks. Before and after 4 and 8 weeks of supplementation, the following variables were measured: resting respiratory rate, heart rate, blood pressure, urinalysis, complete blood count, metabolic panel, liver enzyme activity, and lipid panel. Results: No interaction effects were noted for any variable (p > 0.05), with no changes of statistical significance occurring across time for any of the four conditions (p > 0.05). Conclusion: This is the first study to determine the safety profile of oral higenamine intake in human infjects. Our data indicate that 8 weeks of daily higenamine supplementation, either alone or in conjunction with caffeine and yohimbe bark extract, does not result in a statistically significant change in any of the measured outcome variables. Additional studies, inclusive of a larger sample size, are needed to extend these initial findings.
Publication Title
Human and Experimental Toxicology
Recommended Citation
Bloomer, R., Schriefer, J., & Gunnels, T. (2015). Clinical safety assessment of oral higenamine supplementation in healthy, young men. Human and Experimental Toxicology, 34 (10), 935-945. https://doi.org/10.1177/0960327114565490
